Kopran Ltd KOPRAN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 11:57 AM IST
118.40quote price arrow up+1.00 (+0.85%)
Volume
178,362
52 week range
15.10 - 146.00

...

Loading . . .

KEY STATS

  • Open117.40
  • Day High119.70
  • Day Low116.50
  • Prev Close117.40
  • 52 Week High146.00
  • 52 Week High Date12/04/20
  • 52 Week Low15.10
  • 52 Week Low Date03/13/20
  • Market Cap70.39M
  • Shares Out43.25M
  • 10 Day Average Volume253,813.1
  • Dividend1.50
  • Dividend Yield1.27%
  • Beta
  • 1 Year % Change348.48

RATIOS/PROFITABILITY

  • EPS (TTM)11.87
  • P/E (TTM)9.97
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/05/2020
  • Div Amount1.50
  • Split Date-
  • Split Factor-

Latest Kopran Ltd News

There is no recent news for this security.

Latest KOPRAN-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare. It offers its products in therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others. The Company's bulk drugs include Atenolol, Amlodipine Besylate, Metoprolol...
Surendra Somani
Vice Chairman
Ajit Jain
Chief Operating Officer
Address
Parijat House
1076, Dr. E. Moses Road, Worli
9917
Mumbai
400018
India